dc.contributor.author |
Azad, Farhana |
|
dc.date.accessioned |
2021-09-23T06:55:17Z |
|
dc.date.available |
2021-09-23T06:55:17Z |
|
dc.date.issued |
2016-01-28 |
|
dc.identifier.uri |
http://dspace.ewubd.edu/xmlui/handle/123456789/3220 |
|
dc.description |
This thesis submitted in partial fulfillment of the requirements for the degree of Masters of Pharmacy (M.Pharm) in East West University, Dhaka, Bangladesh. |
en_US |
dc.description.abstract |
This retrospective study was designed to observe the adherence of the new antidiabetic drugs prescribing practice in diabetic hospital of our country. During two months study period, 500 prescription (Diabetic Books prescription and new patients initial form prescription) suffering from diabetes mellitus were enrolled from the BIRDEM, Shahabag, Dhaka. This research revealed that insulin alone or in combination with metformin or alone metformin or alone vildagliptin, sitagliptin, linagliptin or metformin in combination with vildagliptin, sitagliptin, linagliptin and other types of drugs which were prescribed for the treatment of patient suffering from diabetes. Our study found only 19 prescriptions with linagliptin among 500 prescriptions which was only 3.8%. So it can be calculated that linagliptin still seems to be not well accepted by most of the physicians. Another outcome of this study indicated that in 42% prescription there is a practice of old antidiabetic drugs. Furthermore, county wide multicenter research with a large sample is still needed to consolidate the observation of this study. |
en_US |
dc.language.iso |
en_US |
en_US |
dc.publisher |
East West University |
en_US |
dc.relation.ispartofseries |
;PHA00586 (1) |
|
dc.subject |
Diabetes, Antidiabetic drugs, Insulin, Metformin, Vildagliptin, Sitagliptin, Linagliptin. |
en_US |
dc.title |
Linagliptin Prescription in Frequency as Antidiabetic Drug |
en_US |
dc.type |
Thesis |
en_US |